Related Experiment Video
Updated: Aug 15, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Cryptococcal meningitis in Lilongwe and Blantyre, Malawi
1Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Abstract:
Infection with Human Immunodeficiency Virus is widespread in Malawi and cryptococcal meningitis is a common problem in those with AIDS. A review of microbiology laboratory records in Lilongwe and Blantyre between July 1991 and January 1993 identified 31 patients with cryptococcal meningitis. Diagnosis was based on a positive India ink stain of CSF and/or culture of Cryptococcus neoformans. There were 16 men (median age 38 years) and 15 women (median age 28 years) in the investigation. The median duration of symptoms was 2 weeks. The clinical presentation was varied, the most frequent features being headache (97%), neck stiffness (74%), fever (61%) and altered consciousness (58%). CSF WBC count, glucose and protein concentrations were non-specific. Most patients could not afford anti-cryptococcal chemotherapy and their median survival time after diagnosis was 4 days. Patients who could afford such treatment survived for up to several months. Diagnosis is useful for prognostic reasons and may save patients unnecessary treatment if tuberculous meningitis is the alternative diagnosis. Cryptococcal antigen detection tests may improve diagnostic accuracy. The problem of cryptococcal meningitis is likely to become increasingly common as HIV infection becomes more widespread.
Insights
Cryptococcal meningitis is a significant threat for individuals with Human Immunodeficiency Virus (HIV) in Malawi. Limited access to treatment drastically reduces survival rates, highlighting an urgent public health concern.
Area of Science:
- Infectious Diseases
- Neuroscience
- Public Health
Background:
- Human Immunodeficiency Virus (HIV) infection is prevalent in Malawi.
- Cryptococcal meningitis is a frequent opportunistic infection in patients with Acquired Immunodeficiency Syndrome (AIDS).
Purpose of the Study:
- To review cases of cryptococcal meningitis in Malawi.
- To understand the clinical presentation, diagnosis, and outcomes of cryptococcal meningitis in HIV-infected patients.
- To assess the impact of treatment accessibility on patient survival.
Main Methods:
- Retrospective review of microbiology laboratory records from Lilongwe and Blantyre (July 1991 - January 1993).
- Inclusion criteria: positive India ink stain of cerebrospinal fluid (CSF) and/or culture of Cryptococcus neoformans.
- Data collected included patient demographics, symptom duration, clinical features, and survival time.
Main Results:
- 31 patients with cryptococcal meningitis were identified.
- Median symptom duration was 2 weeks; common symptoms included headache (97%), neck stiffness (74%), fever (61%), and altered consciousness (58%).
- Median survival after diagnosis was only 4 days for patients unable to afford treatment, compared to several months for those who could.
Conclusions:
- Cryptococcal meningitis poses a significant challenge in HIV-infected populations in Malawi, with poor outcomes often linked to treatment inaccessibility.
- Accurate and timely diagnosis is crucial for prognosis and to differentiate from other conditions like tuberculous meningitis.
- The increasing prevalence of HIV suggests cryptococcal meningitis will become a more prominent health issue.
Related Concept Videos
Fungal Phylum Microsporidia
Rocky Mountain Spotted Fever
Viral Meningitis
Cryptococcal Meningitis
Toxoplasmosis
Bacterial Meningitis I: Introduction

